Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays

被引:31
作者
Arihiro, Koji
Umemura, Shinobu
Kurosumi, Masafumi
Moriya, Takuya
Oyama, Tetsunari
Yamashita, Hiroko
Umekita, Yoshihisa
Komoike, Yoshifuma
Shimizu, Chikako
Fukushima, Hisaki
Kajiwara, Hiroshi
Akiyama, Futoshi
机构
[1] Hiroshima Univ Hosp, Dept Anat Pathol, Minami Ku, Hiroshima 7348551, Japan
[2] Tokai Univ, Sch Med, Dept Pathol, Kanagawa 2591100, Japan
[3] Kagoshima Univ, Fac Med, Kagoshima 890, Japan
[4] Canc Inst Ariake Hosp, Tokyo, Japan
[5] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan
[6] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan
[7] Kyorin Univ, Sch Med, Tokyo, Japan
[8] Natl Canc Ctr, Tokyo, Japan
关键词
hormone receptors; estrogen receptor; progesterone receptor; immunohistochemistry; automated staining; scoring system; LIGAND-BINDING ASSAY; ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; ANTIGEN RETRIEVAL; PREDICTING RESPONSE; QUALITY ASSURANCE; ROUTINE PRACTICE; CANCER; ANTIBODIES; SECTIONS;
D O I
10.1309/4D1A04NCDK96WFY7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aims of this study were to compare the quality of immunohistochemical assays of estrogen receptor (ER) and progesterone receptor (PR) and to compare the intermethod variability of assays from different manufacturers. Immunohistochemical staining was entrusted to the following laboratories in Japan: Kyowa Medex, dealing with the products of BioGenex (Mishima, Shizuoka), DAKO Japan (Kyoto), and Ventana Japan (Yokohama). All slides were semiquantitatively evaluated according to the Allred score. Intermethod variability showed fair to moderate multirater K values for ER and PR (for total score, ER, K = 0.34; PR, K = 0.45). Another scoring system was also applied in which, irrespective of the intensity of nuclear staining, the proportion of cells stained in each specimen was recorded as 0; less than 1%; 1% or more and less than 10%; or 10% or more. Intermethod variability showed substantial multirater K values for ER and PR (according to percentage of positive cells, ER, K = 0.67, PR, K = 0.72). Concerning intermethod consistency, the scoring system based on the percentage of positive cells was advantageous over other scoring systems.
引用
收藏
页码:356 / 365
页数:10
相关论文
共 47 条
[1]  
Alberts SR, 1996, CANCER-AM CANCER SOC, V78, P764
[2]  
Allred DC, 1998, MODERN PATHOL, V11, P155
[3]  
[Anonymous], 2000, NIH Consens Statement, V17, P1
[4]   Relationship between hormone receptor status and tumour size, grade and comedo necrosis in ductal carcinoma in situ [J].
Barnes, NLP ;
Boland, GP ;
Davenport, A ;
Knox, WF ;
Bundred, NJ .
BRITISH JOURNAL OF SURGERY, 2005, 92 (04) :429-434
[5]   2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology [J].
Bast, RC ;
Ravdin, P ;
Hayes, DF ;
Bates, S ;
Fritsche, H ;
Jessup, JM ;
Kemeny, N ;
Locker, GY ;
Mennel, RG ;
Somerfield, MR .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) :1865-1878
[6]   The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer [J].
Clahsen, PC ;
van de Velde, CJH ;
Duval, C ;
Pallud, C ;
Mandard, AM ;
Delobelle-Deroide, A ;
van den Broek, L ;
van de Vijver, MJ .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1999, 25 (04) :356-363
[7]  
Clarke M, 1998, LANCET, V351, P1451
[8]   Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer [J].
Collins, LC ;
Botero, ML ;
Schnitt, SJ .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (01) :16-20
[9]   Expression of estrogen receptor-α and Ki67 in relation to pathological and molecular features in early-onset infiltrating ductal carcinoma [J].
Ding, SL ;
Sheu, LF ;
Yu, JC ;
Yang, TL ;
Cheng, BF ;
Leu, FJ ;
Shen, CY .
JOURNAL OF BIOMEDICAL SCIENCE, 2004, 11 (06) :911-919
[10]  
Elledge RM, 2000, INT J CANCER, V89, P111, DOI 10.1002/(SICI)1097-0215(20000320)89:2<111::AID-IJC2>3.0.CO